Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 16 de sept. de 2010 · In patients undergoing mechanical ventilation for the acute respiratory distress syndrome (ARDS), neuromuscular blocking agents may improve oxygenation and decrease ventilator-induced lung...

  2. 16 de sept. de 2010 · In patients with severe ARDS, early administration of a neuromuscular blocking agent improved the adjusted 90-day survival and increased the time off the ventilator without increasing muscle weakness.

    • Laurent Papazian, Jean-Marie Forel, Arnaud Gacouin, Christine Penot-Ragon, Gilles Perrin, Anderson L...
    • 2010
  3. 10 de may. de 2019 · The benefits of early continuous neuromuscular blockade in patients with acute respiratory distress syndrome (ARDS) who are receiving mechanical ventilation remain unclear. We randomly assigned...

    • Lung
    • 2019
  4. 21 de ene. de 2020 · The effects of neuromuscular blocking agents (NMBAs) on adult patients with acute respiratory distress syndrome (ARDS) remain unclear. We performed a meta-analysis of randomized controlled trials (RCTs) to evaluate its effect on mortality.

    • Yusi Hua, Xiaofeng Ou, Qian Li, Tao Zhu
    • 10.1371/journal.pone.0227664
    • 2020
    • PLoS One. 2020; 15(1): e0227664.
  5. 28 de ene. de 2020 · Neuromuscular blocking agent (NMBA) has been proposed by medical guidelines for early severe acute respiratory distress syndrome (ARDS) because of its survival benefits. However, new studies have provided evidence contradicting these results.

    • An Thi Nhat Ho, Setu Patolia, Christophe Guervilly
    • 2020
  6. En los pacientes sometidos a ventilación mecánica para el síndrome de dificultad respiratoria aguda (SDRA), los bloqueantes neuromusculares puede mejorar la oxigenación y reducir la ventilación inducida por la lesión pulmonar, pero también puede causar debilidad muscular.

  7. 19 de nov. de 2020 · Objective: To determine whether neuromuscular blocking agents (NMBAs) can decrease the mortality of patients with acute respiratory distress syndrome (ARDS) and improve their clinical outcomes. Design: Systematic review, meta-analysis and meta-regression.